BIOL - Biolase Inc
Previous close
0.053
0 0%
Share volume: 894,472
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$0.05
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-05-12 | 2022-08-11 | 2022-11-10 | 2023-03-28 | 2023-05-11 | |
| Total revenue | 10.166 M | 12.235 M | 12.010 M | 14.051 M | 10.467 M | |
| Cost of revenue | 5.437 M | 7.094 M | 9.565 M | 10.455 M | 7.130 M | |
| Gross profit | 4.729 M | 5.141 M | 2.445 M | 3.596 M | 3.337 M | |
| 8.71% | -52.44% | 47.08% | -7.20% | |||
| Operating expenses | 8.935 M | 10.196 M | 10.096 M | 12.022 M | 8.628 M | |
| Selling general and admin | 7.391 M | 8.543 M | 8.117 M | 9.933 M | 7.081 M | |
| Research and development | 1.544 M | 1.653 M | 1.979 M | 2.089 M | 1.547 M | |
| Total expenses | 14.372 M | 17.290 M | 19.661 M | 22.477 M | 15.758 M | |
| 20.30% | 13.71% | 14.32% | -29.89% | |||
| Operating income | -4.206 M | -5.055 M | -7.651 M | -8.426 M | -5.291 M | |
| Ebit | -4.206 M | -5.055 M | -7.651 M | -8.426 M | -5.291 M | |
| Pretax income | -4.759 M | -5.588 M | -8.404 M | -9.774 M | -5.848 M | |
| 17.42% | 50.39% | 16.30% | -40.17% | |||
| Income tax | 17.000 K | 23.000 K | -17.000 K | 86.000 K | 1.000 K | |
| Net income basic | -4.993 M | -5.611 M | -8.387 M | -9.643 M | -5.849 M | |
| -12.38% | -49.47% | -14.98% | 39.34% | |||
| Net income | -4.993 M | -5.611 M | -8.387 M | -9.643 M | -5.849 M | |
| -12.38% | -49.47% | -14.98% | 39.34% |